pralidoxime has been researched along with Guillain-Barre-Syndrome* in 2 studies
2 other study(ies) available for pralidoxime and Guillain-Barre-Syndrome
Article | Year |
---|---|
Guillain-Barre syndrome due to organophosphate compound poison.
Acute manifestations of Organophosphate Compound (OPC) poison are due to effect cholinergic excess. Others are intermediate syndrome [IMS], organophosphate induced delayed neuropathy [OPIND] and chronic organophosphate induced neuropsychiatric disorder [COPIND]. All these manifestation have specific period of occurrence and duration. There are very sparse reports of toxic demylination due to OPC poisoning. We report a case of Guillain-Barre Syndrome (GBS) due to toxic demyelination following OPC poison. Topics: Adult; Atropine; Chlorpyrifos; Cholinesterase Inhibitors; Cholinesterase Reactivators; Gastric Lavage; Guillain-Barre Syndrome; Humans; Insecticides; Male; Methylprednisolone; Neuroprotective Agents; Parasympatholytics; Plasmapheresis; Pralidoxime Compounds | 2009 |
PAM responsive Gullian Barre like syndrome with low serum cholinesterase.
Topics: Cholinesterases; Environmental Exposure; Follow-Up Studies; Guillain-Barre Syndrome; Humans; India; Insecticides; Organophosphorus Compounds; Pralidoxime Compounds; Treatment Outcome | 1998 |